FI960226A - 9-substituoituja 2-(2-n-alkoksifenyyli)-purin-6-oneja - Google Patents

9-substituoituja 2-(2-n-alkoksifenyyli)-purin-6-oneja Download PDF

Info

Publication number
FI960226A
FI960226A FI960226A FI960226A FI960226A FI 960226 A FI960226 A FI 960226A FI 960226 A FI960226 A FI 960226A FI 960226 A FI960226 A FI 960226A FI 960226 A FI960226 A FI 960226A
Authority
FI
Finland
Prior art keywords
alkoxyphenyl
purin
substituted
Prior art date
Application number
FI960226A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI960226A0 (fi
Inventor
Ulrich Niewoehner
Erwin Bischoff
Helmuth Schuetz
Elisabeth Perzborn
Matthias Schramm
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI960226A0 publication Critical patent/FI960226A0/fi
Publication of FI960226A publication Critical patent/FI960226A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI960226A 1995-01-19 1996-01-17 9-substituoituja 2-(2-n-alkoksifenyyli)-purin-6-oneja FI960226A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19501480A DE19501480A1 (de) 1995-01-19 1995-01-19 9-substituierte 2-(2-n-Alkoxyphenyl)-purin-6-one

Publications (2)

Publication Number Publication Date
FI960226A0 FI960226A0 (fi) 1996-01-17
FI960226A true FI960226A (fi) 1996-07-20

Family

ID=7751828

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960226A FI960226A (fi) 1995-01-19 1996-01-17 9-substituoituja 2-(2-n-alkoksifenyyli)-purin-6-oneja

Country Status (30)

Country Link
US (1) US5866571A (fr)
EP (1) EP0722943A1 (fr)
JP (1) JPH08231546A (fr)
KR (1) KR960029335A (fr)
CN (1) CN1138583A (fr)
AR (1) AR002704A1 (fr)
AU (1) AU4097796A (fr)
BG (1) BG61729B1 (fr)
BR (1) BR9600149A (fr)
CA (1) CA2167349A1 (fr)
CO (1) CO4700524A1 (fr)
CZ (1) CZ16896A3 (fr)
DE (1) DE19501480A1 (fr)
EE (1) EE9600020A (fr)
FI (1) FI960226A (fr)
HR (1) HRP960009A2 (fr)
HU (1) HUP9600107A3 (fr)
IL (1) IL116771A (fr)
MA (1) MA23779A1 (fr)
NO (1) NO960221L (fr)
NZ (1) NZ280829A (fr)
PE (1) PE10597A1 (fr)
PL (1) PL312353A1 (fr)
SG (1) SG47379A1 (fr)
SK (1) SK7696A3 (fr)
SV (1) SV1996000004A (fr)
TN (1) TNSN96005A1 (fr)
TR (1) TR199600701A2 (fr)
YU (1) YU2896A (fr)
ZA (1) ZA96399B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6064072A (en) * 1997-05-12 2000-05-16 Cymer, Inc. Plasma focus high energy photon source
DE19838300A1 (de) * 1998-08-24 2000-03-02 Bayer Ag 9-Dialkylaminopurinon-derivate
US6268372B1 (en) 1998-09-11 2001-07-31 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones
US6124303A (en) * 1998-09-11 2000-09-26 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones
GB9924020D0 (en) * 1999-10-11 1999-12-15 Pfizer Ltd Pharmaceutically active compounds
AUPQ515700A0 (en) * 2000-01-19 2000-02-10 Fujisawa Pharmaceutical Co., Ltd. Imidazole compounds
ES2381862T3 (es) * 2000-09-06 2012-06-01 Mitsubishi Tanabe Pharma Corporation Preparaciones para administración por vía oral
CA2437754C (fr) * 2001-02-15 2010-05-18 Tanabe Seiyaku Co., Ltd. Comprimes a dissolution rapide dans la cavite buccale
US6479493B1 (en) 2001-08-23 2002-11-12 Cell Pathways, Inc. Methods for treatment of type I diabetes
HU228316B1 (en) * 2001-12-13 2013-03-28 Daiichi Sankyo Company Pyrazolopyrimidinone derivatives having pde7-inhibitory activity
US7208516B2 (en) 2002-03-20 2007-04-24 Celgene Corporation Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
US7276529B2 (en) 2002-03-20 2007-10-02 Celgene Corporation Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
CA2480856A1 (fr) * 2002-04-05 2003-10-23 Merck & Co., Inc. Arylamides substituee
JP6687550B2 (ja) 2014-06-23 2020-04-22 セルジーン コーポレイション 肝疾患又は肝機能異常を治療するためのアプレミラスト

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
CA1303037C (fr) * 1987-02-02 1992-06-09 Smith Kline & French Laboratories Limited Derives de purinone utilises comme bronchodilatateurs,vasodilatateurs et agents anti-allergiques
GB8817651D0 (en) * 1988-07-25 1988-09-01 Smith Kline French Lab Chemical compounds
GB9126260D0 (en) * 1991-12-11 1992-02-12 Pfizer Ltd Therapeutic agents
US5294612A (en) * 1992-03-30 1994-03-15 Sterling Winthrop Inc. 6-heterocyclyl pyrazolo [3,4-d]pyrimidin-4-ones and compositions and method of use thereof
US5734053A (en) * 1992-06-26 1998-03-31 Pfizer Inc Purinone antianginal agents
GB9213623D0 (en) * 1992-06-26 1992-08-12 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
HRP960009A2 (en) 1997-12-31
NO960221L (no) 1996-07-22
HUP9600107A3 (en) 1999-06-28
FI960226A0 (fi) 1996-01-17
AR002704A1 (es) 1998-04-29
KR960029335A (ko) 1996-08-17
TNSN96005A1 (en) 2005-03-15
PL312353A1 (en) 1996-07-22
CO4700524A1 (es) 1998-12-29
DE19501480A1 (de) 1996-07-25
MA23779A1 (fr) 1996-10-01
BR9600149A (pt) 1998-01-06
NZ280829A (en) 1998-04-27
CN1138583A (zh) 1996-12-25
BG61729B1 (bg) 1998-04-30
PE10597A1 (es) 1997-06-13
TR199600701A2 (tr) 1996-08-21
CZ16896A3 (en) 1996-08-14
ZA96399B (en) 1996-08-14
HUP9600107A2 (en) 1997-05-28
AU4097796A (en) 1996-07-25
IL116771A0 (en) 1996-05-14
JPH08231546A (ja) 1996-09-10
NO960221D0 (no) 1996-01-18
SV1996000004A (es) 1997-02-19
US5866571A (en) 1999-02-02
YU2896A (sh) 1999-03-04
EP0722943A1 (fr) 1996-07-24
IL116771A (en) 1999-06-20
HU9600107D0 (en) 1996-03-28
SK7696A3 (en) 1996-08-07
CA2167349A1 (fr) 1996-07-20
EE9600020A (et) 1996-08-15
SG47379A1 (en) 1998-04-17
BG100291A (bg) 1996-07-31

Similar Documents

Publication Publication Date Title
DE59510981D1 (de) Bohrfutter
DE69635106D1 (de) Guaninderivat
DE69612854D1 (de) Spannfutter
DE69617471D1 (de) Hochgeschwindigkeitstraversiermechanismus
DE69633171D1 (de) Mutierte luziferasen
FI960226A0 (fi) 9-substituoituja 2-(2-n-alkoksifenyyli)-purin-6-oneja
DE69618742D1 (de) Schaltungsanordnung
DE69616610D1 (de) Spanndorn
ATE198470T1 (de) Alkenyl-benzoylguanidine
DE69619622D1 (de) Schaltungsanordnung
ATE240972T1 (de) Cyclopeptolide
DE59600405D1 (de) Gehhilfe
FI1943U1 (fi) Bomsystem till skogmaskin
FI2196U1 (fi) Snoestyrningsblad till snoeslunga
FI1863U1 (fi) Vaeggkonstruktion till timmerhus
FI2002U1 (fi) Haollare till spoestaell
FI2187U1 (fi) Hoerndetalj till plaottlaoda
FI956132A0 (fi) Kopplingskrok till skjutarm
FIU950360U0 (fi) Mellanlaeggsflaens till axeltaetning
FI954177A0 (fi) Tillaeggsanordning till lyfttruck
FI951168A0 (fi) Kraftoeverfoeringsanordning till rotationskolvmotor
FI955722A0 (fi) Foerfarande foer datafoermedling till fondon
FI955029A0 (fi) Inbrottsskydd till brevlucka
FI950830A0 (fi) Skaer till valskross
FI950473A0 (fi) Vaeggkonstruktion till timmerhus